{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:16:50Z","timestamp":1789903010168,"version":"4.0.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004011","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T18:01:55Z","timestamp":1439575315000},"page":"e0004011","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Miriam","family":"Bolz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Pluschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(99)01156-3","article-title":"Mycobacterium ulcerans infection","volume":"354","author":"TS Van der Werf","year":"1999","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e2252","DOI":"10.1371\/journal.pntd.0002252","article-title":"Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Map\u00e9 Basin of Cameroon","volume":"7","author":"MW Bratschi","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e911","DOI":"10.1371\/journal.pntd.0000911","article-title":"Ecology and transmission of Buruli ulcer disease: a systematic review","volume":"4","author":"RW Merritt","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"KM George","year":"1999","journal-title":"Science"},{"key":"ref5","unstructured":"WHO | Laboratory diagnosis of buruli ulcer. In: WHO [Internet]. [cited 2 Jun 2014]. Available: http:\/\/www.who.int\/buruli\/laboratory_diagnosis\/en\/<\/ext-link>"},{"key":"ref6","unstructured":"WHO | Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans<\/italic> disease (Buruli ulcer). In: WHO [Internet]. [cited 19 Jun 2014]. Available: zotero:\/\/attachment\/245\/"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/AAC.00175-07","article-title":"Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)","volume":"51","author":"A Chauty","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","article-title":"Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial","volume":"375","author":"WA Nienhuis","year":"2010","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/AAC.00299-10","article-title":"Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease","volume":"54","author":"FS Sarfo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"371915","DOI":"10.1155\/2012\/371915","article-title":"Buruli ulcer: treatment challenges at three centres in ghana","volume":"2012","author":"P Agbenorku","year":"2012","journal-title":"J Trop Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4161\/hv.7.11.17751","article-title":"Buruli ulcer","volume":"7","author":"T Einarsdottir","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis","volume":"5","author":"T Prezzemolo","year":"2014","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1462-5822.2005.00546.x","article-title":"Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin","volume":"7","author":"E Coutanceau","year":"2005","journal-title":"Cell Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.00889-06","article-title":"Evidence for an intramacrophage growth phase of Mycobacterium ulcerans","volume":"75","author":"E Torrado","year":"2007","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14712590802631854","article-title":"Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer)","volume":"9","author":"D Sch\u00fctte","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2006.75.768","article-title":"BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin","volume":"75","author":"F Nackers","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda","volume":"70","author":"PG Smith","year":"1976","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref18","first-page":"111","article-title":"BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda","volume":"1","year":"1969","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1371\/journal.pntd.0000985","article-title":"BCG-mediated protection against Mycobacterium ulcerans infection in the mouse","volume":"5","author":"PJ Converse","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e33406","DOI":"10.1371\/journal.pone.0033406","article-title":"Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination","volume":"7","author":"AG Fraga","year":"2012","journal-title":"PloS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from Mycobacterium bovis BCG against Buruli Ulcer","volume":"69","author":"A Tanghe","year":"2001","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1371\/journal.pntd.0000199","article-title":"Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting","volume":"2","author":"A Tanghe","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e2604","DOI":"10.1371\/journal.pntd.0002604","article-title":"Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice","volume":"8","author":"V Roupie","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"MJ Schnell","year":"1996","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/v2020413","article-title":"RNA replicons\u2014a new approach for influenza virus immunoprophylaxis","volume":"2","author":"G Zimmer","year":"2010","journal-title":"Viruses"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"BD Lichty","year":"2004","journal-title":"Trends Mol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e66059","DOI":"10.1371\/journal.pone.0066059","article-title":"Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus","volume":"8","author":"SJ Halbherr","year":"2013","journal-title":"PloS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1128\/JVI.00200-10","article-title":"A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose","volume":"84","author":"MA Cobleigh","year":"2010","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2005.05.046","article-title":"IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors","volume":"24","author":"SD Klas","year":"2006","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants","volume":"106","author":"NF Rose","year":"2001","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"J Publicover","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/CVI.00254-06","article-title":"Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans","volume":"13","author":"D Diaz","year":"2006","journal-title":"Clin Vaccine Immunol CVI"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1128\/IAI.66.6.2625-2631.1998","article-title":"Mapping and identification of the major cell wall-associated components of Mycobacterium leprae","volume":"66","author":"MA Marques","year":"1998","journal-title":"Infect Immun"},{"key":"ref34","first-page":"150","article-title":"Localization of Mycobacterial Antigens by Immunofluorescence Staining of Agarose Embedded Cells","volume":"4","author":"A Vettiger","year":"2014","journal-title":"J Mycobact Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e0003477","DOI":"10.1371\/journal.pntd.0003477","article-title":"Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer","volume":"9","author":"A Dreyer","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1099\/vir.0.80788-0","article-title":"Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes","volume":"86","author":"A Hanika","year":"2005","journal-title":"J Gen Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.vaccine.2008.12.019","article-title":"A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1)","volume":"27","author":"NH Kalhoro","year":"2009","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon","volume":"6","author":"Rentsch M Berger","year":"2011","journal-title":"PloS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(95)00843-X","article-title":"Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase","volume":"371","author":"G Sutter","year":"1995","journal-title":"FEBS Lett"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0958-1669(99)00003-8","article-title":"Recombinant protein expression in Escherichia coli","volume":"10","author":"F Baneyx","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s12879-014-0636-7","article-title":"Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens","volume":"14","author":"MW Bratschi","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-60327-353-4_13","article-title":"Direct detection of Mycobacterium ulcerans in clinical specimens and environmental samples","volume":"943","author":"CJ Lavender","year":"2013","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1128\/AEM.02971-06","article-title":"Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples","volume":"73","author":"JAM Fyfe","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"ref44","unstructured":"Portaels F, Organization WH. Laboratory diagnosis of buruli ulcer: a manual for health care providers \/ edited by Fran\u00e7oise Portaels. Diagnostic de l\u2019ulc\u00e8re de Buruli au laboratoire : manuel destin\u00e9 au personnel de sant\u00e9 \/ edit\u00e9 par Fran\u00e7oise Portaels. 2014; Available: http:\/\/apps.who.int\/\/iris\/handle\/10665\/111738<\/ext-link>"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1099\/vir.0.065201-0","article-title":"Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses","volume":"95","author":"G Zimmer","year":"2014","journal-title":"J Gen Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"W Liao","year":"2013","journal-title":"Immunity"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"DL Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(73)92005-9","article-title":"A CONTROLLED TRIAL OF THE TREATMENT OF MYCOBACTERIUM ULCERANS INFECTION WITH CLOFAZIMINE","volume":"302","author":"WDL Revill","year":"1973","journal-title":"The Lancet"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001290","article-title":"Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer","volume":"5","author":"CL Gordon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e2904","DOI":"10.1371\/journal.pntd.0002904","article-title":"Late onset of the serological response against the 18 kDa small heat shock protein of Mycobacterium ulcerans in children","volume":"8","author":"K R\u00f6ltgen","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.micinf.2006.03.009","article-title":"Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer","volume":"8","author":"E Coutanceau","year":"2006","journal-title":"Microbes Infect Inst Pasteur"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imlet.2012.12.005","article-title":"Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice","volume":"150","author":"JE Johnson","year":"2013","journal-title":"Immunol Lett"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e1925","DOI":"10.1371\/journal.pntd.0001925","article-title":"Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection","volume":"6","author":"TG Martins","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e2183","DOI":"10.1371\/journal.pntd.0002183","article-title":"Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model","volume":"7","author":"G Trigo","year":"2013","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T06:23:19Z","timestamp":1599459799000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004011"}},"subtitle":[],"editor":[{"given":"Christian","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004011","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}